BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30479090)

  • 1. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
    Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
    J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival.
    Ferrari F; Forte S; Ardighieri L; Bonetti E; Fernando B; Sartori E; Odicino F
    Eur J Surg Oncol; 2019 Nov; 45(11):2115-2119. PubMed ID: 31378417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value.
    Rouzier R; Haddad B; Plantier F; Dubois P; Pelisse M; Paniel BJ
    Obstet Gynecol; 2002 Dec; 100(6):1159-67. PubMed ID: 12468158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence and survival in vulvar cancer: A nationwide population-based study.
    Zach D; Åvall-Lundqvist E; Falconer H; Hellman K; Johansson H; Flöter Rådestad A
    Gynecol Oncol; 2021 Jun; 161(3):748-754. PubMed ID: 33736857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
    Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
    Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
    Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva.
    Bogani G; Cromi A; Serati M; Uccella S; Donato VD; Casarin J; Naro ED; Ghezzi F
    Am J Clin Oncol; 2017 Jun; 40(3):235-240. PubMed ID: 25503429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.
    Gasimli K; Straussner M; Schmeil I; Karn T; Winkelmann R; Becker S; El-Balat A
    Arch Gynecol Obstet; 2018 Nov; 298(5):945-950. PubMed ID: 30187190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
    Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
    Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
    Dreyer J; Bremer M; Henkenberens C
    Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
    Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
    [No Abstract]   [Full Text] [Related]  

  • 12. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
    McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
    Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base.
    Chapman BV; Gill BS; Viswanathan AN; Balasubramani GK; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):107-117. PubMed ID: 27843030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.
    Tanaka H; Takenaka Y; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Takemoto N; Cho H; Yamamoto M; Yamamoto Y; Inohara H
    Acta Otolaryngol; 2017 Jun; 137(6):668-673. PubMed ID: 28084858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
    Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
    Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.
    Bedell SM; Hedberg C; Griffin A; Pearson H; Wilhite A; Rubin N; Erickson BK
    Gynecol Oncol; 2019 Aug; 154(2):276-279. PubMed ID: 31171409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcomes for elderly women with vulvar cancer over time.
    Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Dizon DS; Schorge JO; del Carmen MG
    BJOG; 2014 May; 121(6):719-27; discussion 727. PubMed ID: 24621118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.